b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">\n        <PMID Version="1">31217937</PMID>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>02</Month>\n            <Day>25</Day>\n        </DateRevised>\n        <Article PubModel="Print">\n            <Journal>\n                <ISSN IssnType="Print">2008-3866</ISSN>\n                <JournalIssue CitedMedium="Print">\n                    <Volume>22</Volume>\n                    <Issue>5</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>May</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Iranian journal of basic medical sciences</Title>\n                <ISOAbbreviation>Iran J Basic Med Sci</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>The contribution of S100B to the glioprotective effects of valproic and arundic acids.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>557-562</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.22038/ijbms.2019.29852.7204</ELocationID>\n            <Abstract>\n                <AbstractText Label="Objectives" NlmCategory="UNASSIGNED">Valproic and arundic acids are astrocytes-modulating agents with potential effects in the treatment of Alzheimer\'s disease (AD). S100B is an astrocytic cytokine with a possible role in the pathogenesis of AD. In this study, we aimed to assess the glioprotective effects of valproic and arundic acids against amyloid-\xce\xb2-peptide (A\xce\xb2)-induced glial death and contribution of S100B to the glioprotective effects of these agents in an astrocytic culture.</AbstractText>\n                <AbstractText Label="Materials and Methods" NlmCategory="UNASSIGNED">We used A\xce\xb225-35 at a concentration of 200 \xce\xbcM in 1321N1 astrocyte cells. We treated the cells with valproic acid (0.5 and 1 mM) and/or arundic acid 50 \xc2\xb5M for 24 hr. Methylthiazolyldiphenyl-tetrazolium bromide (MTT) test was used to measure cell viability. The intracellular and extracellular S100B levels were measured using an ELISA kit. The data were analyzed using one-way analysis of variance followed by the Tukey\'s test.</AbstractText>\n                <AbstractText Label="Results" NlmCategory="UNASSIGNED">A\xce\xb2 (200 \xc2\xb5M) decreased the cell viability compared to the control group (<i>P</i>&lt;0.001). Valproic acid (0.5 and 1 mM) and arundic acid (50 \xc2\xb5M) ameliorated the gliotoxic effects of A\xce\xb2 (<i>P</i>&lt;0.05). The A\xce\xb2-treated group had higher S100B levels (both intracellular and extracellular) compared to the negative control groups (<i>P</i>&lt;0.001). Arundic and valproic acids (0.5 and 1 mM) decreased both the intracellular and extracellular S100B levels compared to the A\xce\xb2-treated group (<i>P</i>&lt;0.001).</AbstractText>\n                <AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">By considering homeostatic and neuroprotective functions of astrocyte, the astroprotective effects and the attenuation of S100B level may be responsible, at least in part, for the beneficial effects of valproic and arundic acids in AD.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Keshavarz</LastName>\n                    <ForeName>Mojtaba</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Shiraz Neuroscience Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Farrokhi</LastName>\n                    <ForeName>Majid Reza</ForeName>\n                    <Initials>MR</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Shiraz Neuroscience Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Amiri</LastName>\n                    <ForeName>Atena</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Shiraz Neuroscience Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Hosseini</LastName>\n                    <ForeName>Mahshid</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Shiraz Neuroscience Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>Iran</Country>\n            <MedlineTA>Iran J Basic Med Sci</MedlineTA>\n            <NlmUniqueID>101517966</NlmUniqueID>\n            <ISSNLinking>2008-3866</ISSNLinking>\n        </MedlineJournalInfo>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">Amyloid-\xce\xb2-peptide</Keyword>\n            <Keyword MajorTopicYN="N">Arundic acid</Keyword>\n            <Keyword MajorTopicYN="N">Astrocytes</Keyword>\n            <Keyword MajorTopicYN="N">S100B</Keyword>\n            <Keyword MajorTopicYN="N">Valproic Acid</Keyword>\n        </KeywordList>\n        <CoiStatement>All authors have accepted responsibility for the entire content of this submitted manuscript and approved submission. The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.</CoiStatement>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>6</Month>\n                <Day>21</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>6</Month>\n                <Day>21</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>6</Month>\n                <Day>21</Day>\n                <Hour>6</Hour>\n                <Minute>1</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31217937</ArticleId>\n            <ArticleId IdType="doi">10.22038/ijbms.2019.29852.7204</ArticleId>\n            <ArticleId IdType="pmc">PMC6556503</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>Neurobiol Aging. 2000 May-Jun;21(3):383-421</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">10858586</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Neurobiol Aging. 2001 Nov-Dec;22(6):915-22</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11754999</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Cereb Blood Flow Metab. 2002 Jun;22(6):723-34</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12045671</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Science. 2002 Jul 19;297(5580):353-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12130773</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Microsc Res Tech. 2003 Apr 15;60(6):540-51</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12645002</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Brain Res. 2003 May 9;971(2):197-209</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12706236</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Med. 2004 Jul;10(7):719-26</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15195085</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Free Radic Biol Med. 2004 Dec 1;37(11):1790-801</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15528038</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Alzheimers Dis. 2004 Dec;6(6):623-32; discussion 673-81</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15665402</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Cereb Blood Flow Metab. 2005 Jun;25(6):748-62</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15689951</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Curr Drug Targets CNS Neurol Disord. 2005 Apr;4(2):127-42</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15857298</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Neurosci Res. 2006 Apr;83(5):897-906</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16477616</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Eur J Pharmacol. 2006 Jun 6;539(1-2):18-26</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16678157</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Pharmacol Exp Ther. 2006 Aug;318(2):571-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16709678</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Psychiatry. 2006 Dec;11(12):1116-25</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16969367</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Neurosci Res. 2007 May 15;85(7):1506-14</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17387692</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>CNS Drugs. 2008;22(1):27-47</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18072813</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cell Death Differ. 2009 Mar;16(3):378-85</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19057621</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mutat Res. 2010 Aug 7;690(1-2):40-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19748514</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Neuropsychopharmacology. 2010 Mar;35(4):870-80</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20010553</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Glia. 2010 Aug;58(10):1235-46</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20544859</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Neurobiol. 2011 Apr;43(2):87-96</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21161612</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Mol Neurosci. 2012 Mar;46(3):569-77</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21932040</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>ASN Neuro. 2011 Dec 19;3(5):271-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22103264</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cell. 2012 Mar 16;148(6):1204-22</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22424230</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Exp Neurol. 2012 Jul;236(1):1-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22575598</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Anat. 2012 Sep;221(3):252-62</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22738374</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Exp Neurol. 2013 Jan;239:28-37</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23022919</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Curr Drug Targets. 2013 Oct;14(11):1225-36</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23469922</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Neuron. 2014 Jan 22;81(2):229-48</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24462092</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cell Mol Neurobiol. 2014 Aug;34(6):805-12</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24939432</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Neurobiol Dis. 2016 Jan;85:254-261</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25843667</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Cell Neurosci. 2015 Sep;68:203-11</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26260111</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Curr Opin Pharmacol. 2016 Feb;26:74-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26515274</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Exp Neurol. 1995 Jun;133(2):225-30</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">7544290</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Neurosci Lett. 1996 Mar 15;206(2-3):169-72</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">8710178</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann Neurol. 1996 Nov;40(5):759-66</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">8957017</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Neuropathol Exp Neurol. 1997 Aug;56(8):901-11</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">9258260</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Brain Pathol. 1998 Jan;8(1):65-72</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">9458167</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'